logo
#

Latest news with #Injection

Best lip plumpers for fuller and plumper lips: Top 7 picks for that pout perfect selfie
Best lip plumpers for fuller and plumper lips: Top 7 picks for that pout perfect selfie

Hindustan Times

time28-05-2025

  • Health
  • Hindustan Times

Best lip plumpers for fuller and plumper lips: Top 7 picks for that pout perfect selfie

Ever wished for fuller, more luscious lips, without needles or filters? Enter the world of lip plumpers: your beauty shelf's secret weapon for a pout that speaks volumes. These little tubes of magic don't just sit pretty in your makeup bag, they tingle, shine, and work behind the scenes to give your lips a naturally plumped-up look. Be it glossy, red-carpet glam or just want a subtle boost for your everyday look, lip plumpers offer instant pump up and keep your lips fuller and more luscious. So, here are our top 7 picks. Typsy Beauty Glossified 3-in-1 Lip Plumper Balm Gloss delivers glossy shine, deep hydration, and visible plumping in one swipe. Enriched with nourishing ingredients, this lip plumper enhances lip fullness without irritation. The balm-gloss hybrid adds a smooth, non-sticky finish while locking in moisture for all-day comfort. It leaves lips soft, defined, and visibly voluminous with a glass-like shine. LAMEL Full Size Light Holographic Shimmer Lip Plumper offers instant plump and dazzling shine in a full-size gloss. The iridescent shimmer catches the light beautifully while stimulating microcirculation for fuller lips. Infused with peppermint and moisturizing oils, it tingles slightly for a refreshed feel. This lip plumper is perfect for a glam look, and enhances your natural pout with a holographic effect. Makeup Revolution's Rehab Plump Me Up Lip Serum hydrates, smooths, and volumizes in one treatment. This serum-based formula glides on easily, delivering active ingredients like hyaluronic acid and peptides for deep moisture and a plump effect. This plumper softens fine lines on the lips and gives a healthy, fuller appearance over time. Colors Queen Non-Surgical Lip Injection provides instant volume. Formulated with advanced plumping agents, this plumper stimulates circulation and visibly enlarges lips in minutes. It creates a fuller, smoother pout with a tingling sensation that fades as it works. Ideal for quick beauty fixes, it's perfect for bold, plumped-up lips any time, anywhere. Recode Studio Pro Hyaluronic Acid Lip Plumper uses the power of hyaluronic acid to hydrate, smooth, and volumize lips naturally. This formula deeply moisturizes while increasing lip volume with consistent use. It provides a glossy finish and doubles as a lip treatment for long-term improvement. Perfect for daily wear, it softens lips, fades fine lines, and leaves them looking youthful and plush. GLAM21 Plump Play Lip Plumper instantly enhances your pout with a smooth, glossy finish. Its active plumping formula stimulates blood flow to increase lip volume and colour. Designed for a high-shine, glass-like effect, this gloss hydrates and nourishes while making lips appear fuller. Easy to apply and comfortable to wear, it's your go-to for a naturally plumped, glam look. PROTOUCH Long Lasting Lip Plumping Tint combines colour, hydration, and volume for lips that last all day. This lip tint stains lips with a natural flush, while the plumping formula subtly enhances fullness. Lightweight and transfer-resistant, it gives a fresh, long-wear look that doesn't fade or dry out lips. Perfect for minimalists, it offers a tint with benefits in one easy step. Top 8 nude lip glosses inspired by the glamour of the Met Gala; Our picks for you Top 8 matte eyeshadow palettes for elegant and soft eye look; Master the art of eye makeup Top 8 smudge-proof and transfer-proof lipsticks for stunning lips that last long; No fades, no transfer! Top 8 lip liners at Myntra fwd: The art of perfect pout starts here A lip plumper is a cosmetic product designed to temporarily enhance the fullness and appearance of your lips. It often contains ingredients that stimulate circulation or hydration, creating a plumping effect. Lip plumpers work by using ingredients like menthol, capsicum (pepper extract), or hyaluronic acid to increase blood flow or moisture in the lips, causing a fuller appearance. The effect typically lasts between 1 to 4 hours, depending on the formulation and your skin type. Reapplication may be necessary to maintain the look. You may feel a tingling, warming, or slight stinging sensation after application. This is normal and indicates the product is working. If the sensation is painful or causes swelling, discontinue use. Yes! Lip plumper can be worn alone, under lipstick, or on top of lip color for added shine and fullness. Just wait a minute or two after application before layering other products. Disclaimer: At Hindustan Times, we help you stay up-to-date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, with respect to the products. The products listed in this article are in no particular order of priority.

Indivior Announces Patrick Barry as Chief Commercial Officer
Indivior Announces Patrick Barry as Chief Commercial Officer

Associated Press

time27-05-2025

  • Business
  • Associated Press

Indivior Announces Patrick Barry as Chief Commercial Officer

Seasoned commercial executive with more than 30 years of pharmaceutical experience RICHMOND, Va., May 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the appointment of Patrick Barry as Chief Commercial Officer, effective June 2. In this role, Barry will lead the company's commercial growth strategy, execution, and operations as Indivior continues its mission to transform the treatment of opioid use disorder led by SUBLOCADE® (buprenorphine extended-release) Injection. Barry will join Indivior's executive committee. 'Patrick is an accomplished and respected commercial leader whose strong track record driving growth in branded medicines make him an excellent addition to the executive team,' said Joe Ciaffoni, Chief Executive Officer. 'Patrick's breadth and depth of commercial experience will be instrumental in delivering on the Company's potential.' Barry has more than 30 years of commercial leadership experience in the pharmaceutical industry. He brings a track record of building and transforming high-performing commercial organizations to deliver sustained revenue growth across multiple product portfolios. Prior to joining Indivior, Barry served since 2020 as executive vice president and chief commercial officer for Endo Pharmaceuticals. In this role he led all commercial activities across three U.S. business segments, including branded pharmaceuticals and a Canadian affiliate with full responsibility for approximately $2 billion in revenue. 'I am honored to join Indivior at such a pivotal time for the company,' said Barry. 'Indivior has built a strong foundation and is well-positioned to broaden its leadership position in opioid use disorder. I look forward to working with the team to grow SUBLOCADE and maximize the potential of the Indivior portfolio.' Prior to Endo, Barry spent over two decades at Sanofi with increasing levels of responsibility over a range of senior leadership positions, spanning specialty pharmaceuticals, injectables, medical aesthetics, and branded medicines, with demonstrated success in turnaround scenarios, product launches, and market development. Barry holds an MBA from Cornell University and a bachelor's degree in public relations and marketing from McKendree University. About Indivior Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit to learn more. Connect with Indivior on LinkedIn by visiting View original content to download multimedia: SOURCE Indivior PLC

Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan
Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan

Business Upturn

time21-05-2025

  • Business
  • Business Upturn

Biocon subsidiary and Yoshindo expand access to Ustekinumab Biosimilar in Japan

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd, announced that its commercial partner in Japan, Yoshindo Inc., has launched Ustekinumab BS Subcutaneous Injection [YD], a biosimilar version of the reference drug Stelara® (ustekinumab). This biosimilar ustekinumab, developed and manufactured by Biocon Biologics, is being marketed and commercialized in Japan by Yoshindo Inc. Ustekinumab is a monoclonal antibody indicated for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA). The biosimilar was developed and manufactured by Biocon Biologics and received approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) in December 2024. This launch follows a settlement and licensing agreement signed in April 2024 between Biocon Biologics and Janssen Biotech Inc., Janssen Sciences Ireland, and Johnson & Johnson, allowing commercialization of Ustekinumab in Japan after regulatory approval. Biocon Biologics had earlier launched the biosimilar Ustekinumab in the United States and Europe in February 2025, expanding its availability to help patients manage chronic inflammatory conditions. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Yamaha introduces 10-year warranty for all made-in-India two-wheelers
Yamaha introduces 10-year warranty for all made-in-India two-wheelers

India Today

time15-05-2025

  • Automotive
  • India Today

Yamaha introduces 10-year warranty for all made-in-India two-wheelers

Marking 40 years of operations in India, India Yamaha Motor has introduced a 10-year 'Total Warranty' program for its entire made-in-India range of motorcycles and scooters, setting a new standard in two-wheeler reliability and customer comprehensive warranty package includes a 2-year standard warranty and an 8-year extended warranty, covering key components like the engine, electricals, and Fuel Injection (Fi) system. This move aligns with Yamaha's premium brand strategy and its commitment to offering long-term peace of mind to Indian the new scheme, Yamaha's hybrid scooters—Ray ZR Fi and Fascino 125 Fi—as well as the Aerox 155 Version S, will be covered up to 1,00,000 km. The entire locally manufactured motorcycle range, including the FZ series, R15, and MT-15, will be covered for up to 1,25,000 km. Offered at no extra cost to new customers for a limited period, the extended warranty can later be availed at a nominal fee. Notably, the warranty is transferable to subsequent owners, enhancing resale value and reinforcing Yamaha's confidence in its product durability.'This Total Warranty initiative is not just an after-sales offering, but a commitment to long-term customer satisfaction and product reliability,' the company said in an official emphasised that the initiative aims to reduce ownership costs, improve service value, and support a hassle-free riding experience. As the company expands its presence, this warranty rollout underscores Yamaha's focus on building enduring relationships with to Auto Today Magazine

Caplin Point Labs subsidiary gets US FDA nod for schizophrenia treatment drug Haloperidol
Caplin Point Labs subsidiary gets US FDA nod for schizophrenia treatment drug Haloperidol

Business Standard

time14-05-2025

  • Business
  • Business Standard

Caplin Point Labs subsidiary gets US FDA nod for schizophrenia treatment drug Haloperidol

Caplin Point Laboratories said that its subsidiary Caplin Steriles has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Haloperidol Decanoate Injection. The approved drug is a generic therapeutic equivalent version of the reference listed drug (RLD) HALDOL (haloperidol decanoate) Injection, by Janssen Pharmaceuticals Inc. Haloperidol Decanoate Injection indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy. According to IQVIA (IMS Health), Haloperidol Decanoate Injection had US sales of approximately $16.4 million for the 12-month period ending March 2025. Caplin Steriles is a sterile product manufacturing company that is approved by several regulatory agencies such as US FDA, EU-GMP, ANVISA and INVIMA. It has developed and filed 48 ANDAs in USA on its own and with partners, with 38 approvals so far. Caplin Point Laboratories is a pharmaceutical company with a unique business model catering predominantly to emerging markets in Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms. The companys consolidated net profit grew 18.6% to Rs 138.96 crore on a 13.2% increase in revenue from operations to Rs 492.96 crore in Q3 FY25 over Q3 FY24. The scrip rose 0.25% to currently trade at Rs 2009.65 on the BSE.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store